Melissa Bello-Perez

10PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersPhotography, video and lens-based practiceCancer diagnosisPharmacogenomicsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 03, 2026
Human papillomavirus 68 subtypes among people with human immunodeficiency virus and implications for anal screening.

|Nov 14, 2025
Virological Success With Long-Acting Cabotegravir and Rilpivirine Despite Historical Rilpivirine Resistance: A Real-World Case Series.

Félix Gutiérrez, Marta Fernández-González, Christian Ledesma

|Jul 24, 2025
ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology.

Melissa Bello-Perez, Paula Mascarell, Marta Fernández-González

|Jun 05, 2025
Influence of patient characteristics and oral lead-in on long-acting cabotegravir and rilpivirine pharmacokinetics and outcomes in people with HIV: a real-world study.

Marta Fernández-González, Guillermo Telenti, Christian Ledesma

|Mar 05, 2025
Impact of Switching to Long-Acting Injectable Cabotegravir Plus Rilpivirine on Rectal HIV-1 RNA Shedding and Implications for Transmission Risk.

Mar Masiá, Marta Fernández-González, Christian Ledesma

|Sep 19, 2024
Virological History Predicts Non-sustained Viral Suppression With Long-Acting Cabotegravir and Rilpivirine Therapy, Independent of Pharmacokinetic Parameters.

Félix Gutiérrez, Marta Fernández-González, Christian Ledesma

Pageof 2

Frequent Collaborators

5 joint publications

Marta Fernández-González

5 joint publications

Javier García-Abellán

5 joint publications

Félix Gutiérrez

5 joint publications

Mar Masiá